66
Views
7
CrossRef citations to date
0
Altmetric
Review

Vesicular carrier constructs for topical immunisation

, PhD, , M Pharm & , PhD
Pages 341-348 | Published online: 07 Aug 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Chukwuemeka C Mbah, Philip F Builders & Anthony A Attama. (2014) Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus. Expert Opinion on Drug Delivery 11:1, pages 45-59.
Read now
Amornrat Viriyaroj, Tanasait Ngawhirunpat, Monrudee Sukma, Prasert Akkaramongkolporn, Uracha Ruktanonchai & Praneet Opanasopit. (2009) Physicochemical properties and antioxidant activity of gamma-oryzanol-loaded liposome formulations for topical use. Pharmaceutical Development and Technology 14:6, pages 665-671.
Read now
John A Mikszta & Philippe E Laurent. (2008) Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook. Expert Review of Vaccines 7:9, pages 1329-1339.
Read now

Articles from other publishers (4)

Chukwuemeka Mbah, Josephat Ogbonna, Ifeanyi Nzekwe, George Ugwu, Richard Ezeh, Philip Builders, Anthony Attama, Michael Adikwu & Sabinus Ofoefule. (2021) Nanovesicle Formulation Enhances Anti-inflammatory Property and Safe Use of Piroxicam. Pharmaceutical Nanotechnology 9:3, pages 177-190.
Crossref
Douglas S. Watson, Aaron N. Endsley & Leaf Huang. (2012) Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine 30:13, pages 2256-2272.
Crossref
Afendi Dahlan, H. Oya Alpar & Sudaxshina Murdan. (2009) An investigation into the combination of low frequency ultrasound and liposomes on skin permeability. International Journal of Pharmaceutics 379:1, pages 139-142.
Crossref
Minghuang Hong, Saijie Zhu, Yanyan Jiang, Guotao Tang & Yuanying Pei. (2009) Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. Journal of Controlled Release 133:2, pages 96-102.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.